ALK and malignant peritoneal mesothelioma: Recent works have highlighted the presence of Anaplastic Lymphoma Kinase (ALK) gene alterations in a subgroup of MPM [30,31,32,33], similarly to peritoneal malignant mesothelioma occurring in young patients, then representing a novel pathogenetic event and a formidable target for specific ALK inhibitors [32].